Population and Public Health

A potentially shortened battery life in the MiniMed 600 or 700 series insulin pumps may result in the pump stopping insulin delivery significantly sooner than expected.

Also, See-Mode has received the first US FDA approval for a thyroid ultrasound analysis AI solution.

Also, Japan has approved iRhythm's AI-based continuous ECG monitoring system.

Cardiothoracic surgeon at Ochsner Lafayette Hospital Dr. Antoine Keller talks about using technology and artificial intelligence to promote access and help the underserved, and details a project that utilizes a portable diagnostic tool.  

A Korean startup has developed a non-cloud diary app that records a user's voice to spot signs of depression.

Dr. Jenna Glover, chief clinical officer at Headspace, discusses the company's alliance with Spring Fertility and its stance on reproductive rights in a volatile political climate.

Children's National Hospital, Texas Tech University Health Sciences Center, Arcare and AbleTo are facilities practicing quality telemedicine and delivering care to underserved populations, says Dr. Shawn Griffin, president and CEO at URAC.

QuantHealth cofounder and CEO Orr Inbar discusses how using artificial intelligence for clinical trial simulations can help solve challenges often seen by patients, researchers and the pharmaceutical industry when studying a new drug.

Waltz Health partners with Reliance Rx for specialty drug access, and Marshall Health Network and Primefocus Health collaborate on services for regional healthcare.

Dr. Raghav Murali-Ganesh, cofounder and CEO of Osara Health, discusses the rise of cancer diagnosis thanks to diagnostic technologies and tools, advances in patient treatments and how Osara advances positive behavioral transformation.